Publicacions (35) Publicacions de Ángel Ernesto Amesty Arrieta

2024

  1. 1,2,3-Triazole-totarol conjugates as potent PIP5K1α lipid kinase inhibitors

    Bioorganic and Medicinal Chemistry, Vol. 105

2023

  1. Labdane conjugates protect cardiomyocytes from doxorubicin-induced cardiotoxicity

    Drug Development Research, Vol. 84, Núm. 1, pp. 84-95

  2. Methyl esters of 23,24-Dinor-5α-cholan-22-oic acids as brassinosteroid Analogues. Synthesis, evaluation of plant growth promoting activity and Molecular docking

    Steroids, Vol. 196

  3. Phenolic and quinone methide nor-triterpenes as selective NLRP3 inflammasome inhibitors

    Bioorganic Chemistry, Vol. 132

  4. Synthesis and biological evaluation of anthracene-9,10 dione derivatives as CK2 inhibitors

    Results in Chemistry, Vol. 6

2022

  1. Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking

    Pharmaceuticals, Vol. 15, Núm. 7

  2. Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones

    Pharmaceuticals, Vol. 15, Núm. 5, pp. 585

  3. Discovery of Highly Functionalized 5-hydroxy-2H-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen

    Cancers, Vol. 14, Núm. 21

  4. Flavonoids from Piper Species as Promising Antiprotozoal Agents against Giardia intestinalis: Structure-Activity Relationship and Drug-Likeness Studies

    Pharmaceuticals, Vol. 15, Núm. 11

2021

  1. JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

    Biomedicine and Pharmacotherapy, Vol. 144

  2. Modular synthesis and antiproliferative activity of new dihydro-1H-pyrazolo[1,3-b]pyridine embelin derivatives

    Pharmaceuticals, Vol. 14, Núm. 10

  3. Synthesis and fungicidal activity of hydrated geranylated phenols against botrytis cinerea

    Molecules, Vol. 26, Núm. 22

2020

  1. Dehydrohispanolone Derivatives Attenuate the Inflammatory Response through the Modulation of Inflammasome Activation

    Journal of Natural Products, Vol. 83, Núm. 7, pp. 2155-2164

  2. Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors

    Bioorganic Chemistry, Vol. 95

  3. Development of an in vitro screening assay for PIP5K1α lipid kinase and identification of potent inhibitors

    FEBS Journal, Vol. 287, Núm. 14, pp. 3042-3064

  4. Efficient Multicomponent Synthesis of Diverse Antibacterial Embelin-Privileged Structure Conjugates

    Molecules (Basel, Switzerland), Vol. 25, Núm. 14

  5. Withanolide-Type Steroids from Withania aristata as Potential Anti-Leukemic Agents

    Molecules (Basel, Switzerland), Vol. 25, Núm. 23

2019

  1. A novel naphthoquinone-coumarin hybrid that inhibits BCR-ABL1-STAT5 oncogenic pathway and reduces survival in imatinib-resistant chronic myelogenous leukemia cells

    Frontiers in Pharmacology, Vol. 9, Núm. JAN

  2. Expanding the Chemical Space of Withaferin A by Incorporating Silicon to Improve Its Clinical Potential on Human Ovarian Carcinoma Cells

    Journal of Medicinal Chemistry, Vol. 62, Núm. 9, pp. 4571-4585

  3. Metal complexes of natural product like-compounds with antitumor activity

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 19, Núm. 1, pp. 48-65